Stocks swing after a major publisher retracts explosive claims linking a mobile ad firm to illicit activity. Software giant shares rally on renewed optimism tied to big tech capital spending and AI. A health company faces legal trouble over alleged copycat obesity drugs while workforce software moves falter amid leadership changes.
05:13
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
AppLovin Rally After Retraction
AppLovin stock jumped after a publisher retracted explosive allegations about ties to crime syndicates.
The move shows how reputational claims and retractions can drive volatile swings in tech stocks.
insights INSIGHT
Oracle Lifted By AI Spend Signals
Oracle rallied sharply as analysts weighed its AI ties and big-tech capex eased AI-related fears.
The stock's move highlights how broader tech spending announcements can sway software bellwethers.
question_answer ANECDOTE
Trump Boosts Tegna Deal Odds
Tegna spiked after President Trump expressed support for the Nexstar acquisition on Truth Social.
Carol Massar noted regulatory backing can materially increase the odds of deal closure.
Get the Snipd Podcast app to discover more snips from this episode
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Matt Miller, Katie Greifeld, Carol Massar and Tim Stenovec
On this episode of Stock Movers:
- Applovin (APP) stock surged Monday after a financial publisher retracted some of its most explosive claims regarding AppLovin's alleged connections to transnational crime syndicates. Capitalwatch, a self-described independent news organization and publisher, accused AppLovin of serving as a "laundering machine" for illicit funds from Southeast Asia. It described major shareholder Hao Tang as the key facilitator of this scheme.
- Oracle (ORCL) shares extended their rebound on Monday, as ramped up capex spending by US technology giants helped soothe nerves over the threat posed to the company by developments in artificial intelligence. Shares in the software bellwether rallied as much as 12%, their biggest intraday rise since Sept. 10. Even with that move — which came on the heels of Amazon.com Inc.’s pledge to spend $200 billion this year on data centers, chips and other equipment — the stock is down around 50% from its September highs.
- Hims & Hers Health (HIMS) stocks fell after Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill.
Stock Movers